Want to contact a Skelid lawyer in Washington, DC? ...Get a free case evaluation from one of our Skelid lawyers in Washington, DC now.

Skelid - News Articles

Business finance news - currency market news - online UK currency markets - financial news - Interactive Investor


Interactive Investor Trading Limited, trading as "Interactive Investor", is authorised and regulated by the Financial Services Authority. Registered Office: Standon House, 21 Mansell Street, London E1 8AA, telephone 0845 ...
Osteoporosis: Eight Tips to Protect Your Bones - ABC News


Perhaps you want to know about other ways to strengthen your bones before going on bisphosphonates. Or maybe you already take these medications, but you want to see what else you can do to ensure that your bones are as strong ...
Fosamax Fracture Cases Cause Women to Weigh Risk of Using Bone-Loss Drug - ABC News


Just this week ABC's Dr. Richard Besser reported that Fosamax, one of a class of bisphosphonates used to treat osteoporosis that is supposed to make bones stronger, may actually weaken them after long-term use. The U.S. Food and Drug Administration announced today ...
PR-USA.net - Tarsa Therapeutics Announces Addition of Senior Level Clinical and Regulatory Expertise


where he played a key role in the regulatory strategy that led to approval of Plavix and directed early clinical efforts for the bisphosphonate Skelid®. ...
CNW Telbec | NOVARTIS PHARMACEUTICALS CANADA INC. | Common Drug Review refuses to recommend public access of unique once-yearly osteoporosis treatment
Jul 2, 2008
CNW Telbec (Communiqués de presse), Canada -
Aclasta(*) offers a convenient, safe and effective alternative to oral bisphosphonates that are taken daily or weekly. "The CDR's recommendation on ...
Bloomberg.com: Invest
Jul 3, 2008
Bloomberg -
By Lisa Rapaport July 3 (Bloomberg) -- Amgen Inc.'s experimental osteoporosis drug may become the top remedy for the bone- thinning disorder, gaining about half of an $8 billion annual market and reviving shares. ...
RTTNews - Quick facts Articles, Positive EPS Surprises, News Analysis, Earnings, Audio News....
Jul 2, 2008
RTT News, NY -
(RTTNews) - Novartis Pharmaceuticals Canada Inc., a division of Novartis AG (NVS: News, Chart, Quote ), said that the Common Drug Review, Canada's national ...
RTTNews - Breaking News, financial breaking News, Positive EPS Surprises, Stock research ....
Jul 2, 2008
RTT News, NY -
(RTTNews) - Novartis Pharmaceuticals Canada Inc., a division of Basel, Switzerland-based healthcare solutions provider Novartis AG (NVS: News, Chart, ...
Common drugs may combat aging disease - genetics - 02 July 2008 - New Scientist
Jul 2, 2008
New Scientist (subscription), UK -
Statins, which are used to reduce cholesterol, and bisphosphonates, which curb osteoporosis, are known to reduce farnesyl levels, so Carlos López-Otín of ...
Chemo May Limit Fertility in Breast Cancer Survivors - washingtonpost.com
May 31, 2008
Washington Post, United States -
SATURDAY, May 31 (HealthDay News) -- Chemotherapy may reduce fertility in breast cancer survivors, according to a study led by researchers at Boston's ...
ABC News: Bone Drug Offers Hope on Breast Cancer
May 31, 2008
ABC News -
By AUDREY GRAYSON Some early-stage breast cancer patients may soon have an alternative to chemotherapy. A major study, released today, found that a drug commonly known to treat brittle bones also showed promise in dealing with early-stage breast cancer and could change the ...
Bone Drug Lowers Risk of Breast Cancer Recurrence - US News and World Report
May 31, 2008
U.S. News & World Report, DC -
By Amanda Gardner SATURDAY, May 31 (HealthDay News) -- A drug used to treat osteoporosis lowered the risk of breast cancer recurrence in premenopausal women with early breast cancer. Related News Video: Health News ...
Bloomberg.com: Science
May 31, 2008
Bloomberg -
By Michelle Fay Cortez and Eva von Schaper May 31 (Bloomberg) -- Novartis AG's bone-strengthening drug Zometa unexpectedly cut the risk that breast tumors would return in a study of young women getting the therapy, which protects bones from the ravages of cancer. ...
AFP: Avastin plus Taxotere slows advanced breast cancer: study
May 31, 2008
AFP -
CHICAGO (AFP) — A treatment combining Avastin, which stems the blood supply to tumors, with cell division blocker Taxotere slows the progression of advanced breast cancer, said an international clinical study presented Saturday. In earlier studies, Avastin (a trade name for the ...
Free Preview - WSJ.com
May 31, 2008
Wall Street Journal -
By JACOB GOLDSTEIN Zometa, a Novartis AG bone drug, significantly reduces the risk that breast cancer will return in certain patients, researchers said. The drug is approved to help cancer patients maintain bone strength, but this is the first large study to ...
BBC NEWS | Health | 'I had to fight for my babies'
May 31, 2008
BBC News, UK -
By Jane Elliott When Hilary Blackburn was diagnosed with breast cancer, she feared she would never have the children she longed for. She learnt of her illness aged 32, just months before her wedding, and was determined not ...
The New York Times > Log In
May 31, 2008
New York Times, United States -
By ANDREW POLLACK CHICAGO — The drug Erbitux lengthened the survival of patients with advanced lung cancer by about five weeks, researchers are reporting ...
AFP: New drug cocktails show promise against breast cancer: studies
Jun 1, 2008
AFP -
CHICAGO (AFP) — New drug cocktails have shown promise in the fight against breast cancer, a diseases that annually kills more than half an million of women around the world, two new studies show. The research was unveiled at an annual meeting here of the ...
Bone drug Zometa helps women with early breast cancer - USATODAY.com
Jun 1, 2008
USA Today -
By Liz Szabo, USA TODAY A bone-building drug also may help certain women with early breast cancer, a study shows. Breast cancer patients who took the drug Zometa, in addition to hormonal therapy, were 35% less likely to relapse than those given placebos, according to a ...
ASCO data move cancer-drug stocks - MarketWatch
Jun 2, 2008
MarketWatch -
By Val Brickates Kennedy, MarketWatch BOSTON (MarketWatch) -- While drug stocks trended downward overall Monday afternoon, several well-known cancer-drug developers saw their shares rally on positive drug data delivered at the annual meeting in Chicago of the American ...
Want to contact a Skelid lawyer in Washington, DC? ...Get a free case evaluation from one of our Skelid lawyers in Washington, DC now.

Pages:   1   2   3   4   5   6   ...   Next

AddThis Social Bookmark Button

 

Need A Skelid Attorney?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Please Describe the Injury
Click to Ask a Question

Your Friend's Email Address

Your Email Address

Type a Message (optional)


 

Need A Skelid Lawyer?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Please Describe the Injury
Click to Ask a Question

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Skelid Case - Submit Your Information Below

Do you need legal assistance with your Skelid case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * Unsafe Drugs: Skelid Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.